Source: International Congress 2019 – Rare lung diseases
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
L. Fregonese (London, United Kingdom). How to assist bringing new drugs to patients: role of the European Medicines Agency. International Congress 2019 – Rare lung diseases

Member's Comments

No comment yet.

Related content which might interest you: The Innovative Medicines Initiative (IMI), a promising partnership to deliver new medicines to patients Source: Year: 2008 National example: Italian Medicines' Agency Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines Year: 2014 Medicines for children in Europe: from proposals to practicalities Source: Eur Respir J 2010; 35: 228-229 Year: 2010 The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level Source: Eur Respir J 2008; 31: 924-926 Year: 2008 Better Medicines for Children - European regulation, European research networks, Funding opportunities Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening Year: 2006 Policy implementation for the ban of characterising flavours in tobacco products in the European Union: The EUREST-FLAVOURS Project Source: International Congress 2019 – From the epidemiology of tobacco/electronic nicotine delivery system use to control and prevention of tobacco use Year: 2019 Innovative Medicines Initiatives (IMI) Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines Year: 2014 Involving patients in developing, refining and testing an implementation strategy to promote asthma self-management using the National Standards for Public Involvement Source: International Congress 2019 – Innovations in primary care assessment and management Year: 2019 The ERS European Forum for TB Innovation in Europe: a new way to raise innovation Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management Year: 2013 The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP) Source: Eur Respir J, 49 (5) 1602295; 10.1183/13993003.02295-2016 Year: 2017 The ERS Research Agency: the beginning Source: Eur Respir J 2016; 47: 1017-1023 Year: 2016 Medicines for Children - the UK experience Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening Year: 2006 Health Research collaboration in Europe: an innovative initiative Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research Year: 2013 European Union Standards for Tuberculosis Care Source: Eur Respir J 2012; 39: 807-819 Year: 2012 Health care professionals's features of an ideal inhaler in testing new inhaler device. Does it recognize their needs? Source: International Congress 2014 – Medical education: web and internet Year: 2014 Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease Source: Eur Respir J 2016; 47:1345-1347 Year: 2016 The future of health care. The perspective of the UK Health Policy Makers Source: ERS Summit on priorities in respiratory medicine 2011 Year: 2011